Makers Laboratories Limited (BOM:506919)
India · Delayed Price · Currency is INR 145.10
+10.25 (7.60%)
At close: Feb 12, 2026
Makers Laboratories Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Operating Revenue | 1,387 | 1,208 | 1,044 | 1,013 | 1,272 | 686.41 |
Other Revenue | - | - | - | - | 9.65 | - |
| 1,387 | 1,208 | 1,044 | 1,013 | 1,282 | 686.41 | |
Revenue Growth (YoY) | 21.01% | 15.67% | 3.07% | -20.98% | 86.72% | 33.55% |
Cost of Revenue | 672.11 | 565.67 | 561.9 | 422.82 | 537.25 | 300.3 |
Gross Profit | 715.35 | 641.84 | 481.99 | 589.96 | 744.41 | 386.11 |
Selling, General & Admin | 160.82 | 148.61 | 144.02 | 120.76 | 127.85 | 90.16 |
Other Operating Expenses | 429.02 | 409.34 | 322.82 | 432.16 | 415.5 | 213.06 |
Operating Expenses | 632.81 | 605.81 | 512.28 | 595.34 | 583.59 | 349.32 |
Operating Income | 82.54 | 36.03 | -30.29 | -5.38 | 160.82 | 36.79 |
Interest Expense | -5.78 | -10.83 | -17.56 | -19.02 | -14.39 | -14.65 |
Interest & Investment Income | 3.8 | 3.8 | 5.92 | 8.79 | 7.5 | 1.15 |
Currency Exchange Gain (Loss) | 3.86 | 3.86 | 3.84 | 7.04 | 4.31 | 3.34 |
Other Non Operating Income (Expenses) | -9.11 | -1.94 | -1.53 | 0.13 | -0.05 | -2.86 |
EBT Excluding Unusual Items | 75.31 | 30.92 | -39.61 | -8.43 | 158.2 | 23.78 |
Gain (Loss) on Sale of Investments | 2.72 | 2.72 | 0.1 | 0.01 | 0.74 | 3.25 |
Gain (Loss) on Sale of Assets | 1.89 | 102.89 | 0.56 | 0.18 | -0.52 | 0.03 |
Asset Writedown | -0.2 | -0.2 | -0.23 | -0.14 | -1.61 | - |
Other Unusual Items | 5.52 | -2.22 | - | - | 0.08 | - |
Pretax Income | 85.23 | 134.11 | -39.17 | -8.39 | 156.88 | 27.05 |
Income Tax Expense | 26.41 | 25.03 | 8.94 | 13.53 | 39.71 | 13.56 |
Earnings From Continuing Operations | 58.82 | 109.08 | -48.11 | -21.92 | 117.17 | 13.49 |
Minority Interest in Earnings | -46.7 | -34.17 | -14.54 | -25.59 | -67.39 | -16.78 |
Net Income | 12.13 | 74.91 | -62.64 | -47.51 | 49.78 | -3.29 |
Net Income to Common | 12.13 | 74.91 | -62.64 | -47.51 | 49.78 | -3.29 |
Net Income Growth | -80.60% | - | - | - | - | - |
Shares Outstanding (Basic) | 6 | 6 | 6 | 6 | 5 | 5 |
Shares Outstanding (Diluted) | 6 | 6 | 6 | 6 | 5 | 5 |
Shares Change (YoY) | 0.01% | - | -1.89% | 22.31% | - | - |
EPS (Basic) | 2.05 | 12.70 | -10.62 | -7.90 | 10.12 | -0.67 |
EPS (Diluted) | 2.05 | 12.70 | -10.62 | -7.90 | 10.12 | -0.67 |
EPS Growth | -80.60% | - | - | - | - | - |
Free Cash Flow | - | -80.2 | -57.82 | -215.27 | 86.1 | - |
Free Cash Flow Per Share | - | -13.59 | -9.80 | -35.80 | 17.51 | - |
Gross Margin | 51.56% | 53.15% | 46.17% | 58.25% | 58.08% | 56.25% |
Operating Margin | 5.95% | 2.98% | -2.90% | -0.53% | 12.55% | 5.36% |
Profit Margin | 0.87% | 6.20% | -6.00% | -4.69% | 3.88% | -0.48% |
Free Cash Flow Margin | - | -6.64% | -5.54% | -21.25% | 6.72% | - |
EBITDA | 128.2 | 80.32 | 12.16 | 34.2 | 198.23 | 54.11 |
EBITDA Margin | 9.24% | 6.65% | 1.16% | 3.38% | 15.47% | 7.88% |
D&A For EBITDA | 45.67 | 44.29 | 42.45 | 39.57 | 37.41 | 17.31 |
EBIT | 82.54 | 36.03 | -30.29 | -5.38 | 160.82 | 36.79 |
EBIT Margin | 5.95% | 2.98% | -2.90% | -0.53% | 12.55% | 5.36% |
Effective Tax Rate | 30.99% | 18.67% | - | - | 25.31% | 50.14% |
Revenue as Reported | 1,398 | 1,326 | 1,059 | 1,036 | 1,298 | 695.97 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.